Ledger.Open graph →
SEC Form D · Amendment · filed November 12, 2020

RECURSION PHARMACEUTICALS, INC

Offering
$245.9M
Sold
$245.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

William R. Cowen · Needham, MAExec · Director · PromoterRobert C. Hershberg · SALT LAKE CITY, UTDirectorSteve M. Ritchie · Louisville, KYDirectorMatthew B. Popoli · Boston, MADirectorR. M. Chavez · SALT LAKE CITY, UTDirectorZavain P. Dar · MENLO PARK, CADirectorChrista Dorrego · New York, NYDirectorLeonard P. Hedge · Needham, MAExec · PromoterTerry-Ann C. Burrell · SALT LAKE CITY, UTDirectorBlake C. Borgeson · SALT LAKE CITY, UTDirectorJonathan S. Katz · New York, NYDirectorNicolas Barthelemy · San Diego, CADirectorZachary C. Bogue · PALO ALTO, CADirectorPeter Diamandis · Naples, FLExec · PromoterKyu Jo · New York, NYDirectorChris Neary · San Diego, CADirectorVasudev Kulkarni · New York, NYDirectorPaul Conley · San Diego, CADirectorRichard Ruffer · Wilmington, DEDirectorDean C. Li · SALT LAKE CITY, UTDirectorGonzalo Trenosky · Fort Mill, SCDirectorGrant P. Gund · Needham, MADirectorChristopher C. Gibson · SALT LAKE CITY, UTExec · Director · PromoterAthena Demos · Van Nuys, CAExec · Director · PromoterAshish Dodia · Wilmington, DEDirectorJose Morachis · SAN DIEGO, CADirectorMichael M. Secora · SALT LAKE CITY, UTExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗